| Financial Year |
March 31 2023 |
| Monetary Funds |
7,457,960,252.30 |
| Held-for-trading Financial Assets |
503,229,166.67 |
| Notes Receivable |
-- |
| Accounts Receivable |
-- |
| Advances to Suppliers |
61,245,047.38 |
| Other Receivables |
41,747,546.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
88,845.35 |
| Dividend Receivable |
-- |
| Inventories |
1,261,257,298.40 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,141,585.01 |
| Total Current Assets |
9,387,580,896.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
465,681,296.62 |
| Investment Properties |
-- |
| Fixed Assetes |
3,247,230,367.49 |
| Under-construction Projects |
30,987,517.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
403,802,094.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
38,936,157.96 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
457,830,228.16 |
| Sub-Total of Non-Current Assets |
4,690,127,906.53 |
| Total Assets |
14,077,708,802.66 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
521,359,363.92 |
| Accounts Received In Advance |
5,510,822.18 |
| Employee Compensation Payable |
530,636,313.97 |
| Taxes Payable |
81,457,804.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
953,773,609.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,806,590.75 |
| Other Current Liabilities |
124,697,264.31 |
| Sub-Total of Current Liabilities |
6,446,846,311.70 |
| Long-term Loans |
2,984,954.93 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
137,271.31 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
150,360,046.87 |
| Total Liabilities |
6,597,206,358.57 |
| Paid-In Capital(Or Share Stock) |
1,777,679,909.00 |
| Capital Surplus |
2,420,265,350.43 |
| Surplus Reserve |
2,062,683,286.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,460,627,194.10 |
| Minority Stockholder's Interest |
-239,588,851.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,720,091,295.72 |
| Owner's Equity（Stockholder's Equity） |
7,480,502,444.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,077,708,802.66 |
